The U.S. Food and Drug Administration today approved Viekira Pak (ombitasvir, paritaprevir and ritonavir tablets co-packaged with dasabuvir tablets) to treat patients with chronic hepatitis C virus (HCV) genotype 1 infection, including those with a type
Read More...
Read the complete post at http://blog.aids.gov/2014/12/fda-approves-viekira-pak-to-treat-hepatitis-c.html
Posted
Dec 19 2014, 01:11 PM
by
blog.aids.gov — HIV Policy & Programs. Research. New Media.